Hyderabad: Bharat Biotech on Saturday said it received DCGI approval for emergency use of Covaxin for children aged 12-18 years. The vaccine has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. “We have documented excellent safety and immunogenicity data readouts in children. We look forward for […]
India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines.
"Following the emergency use permission, the company is in a position to meet any production requirement that the government may have at this time,” company officials said
While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. Covaxin has generated excellent safety data with robust immune responses
This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.
While many countries rely on their own regulatory systems for vaccine approvals, some countries with weak system depend on WHO's nod to a great extent for rolling out their national vaccination programmes.
Noel Wathion, number two at the European Medicines Agency, told Belgian newspaper Het Nieuwsblad on Tuesday that the approval for AstraZeneca-Oxford vaccine is still "unthinkable" and Europe
